| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037910 Pyridazino[6,1-c ][1,2,4]triazin-4-ones; mediate physiological and psychotropic effects; antagonists; antiemetics; |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037536 α-amylase activity inhibitors |
| 05/02/2006 | US7037529 Spraying a suspension of microionized fenofibrate and polyvinylpyrrolidone onto an inert hydrosoluble carrier; immediate-release; improved dissolution |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 04/27/2006 | WO2006044961A1 Ppar-gamma modulatores |
| 04/27/2006 | WO2006044556A2 Dual inhibitors of lipoxygenase for treating diabetes |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | WO2006044293A2 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2006044174A2 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 04/27/2006 | WO2006043966A2 Methods for inducing apoptosis in adipocytes |
| 04/27/2006 | WO2006043728A1 Method of screening insulin resistance-improving agent |
| 04/27/2006 | WO2006043701A1 Method of inhibiting phosphorylation of transcriptional factor for gluconeogenesis-associated gene and phosphorylation inhibitor |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043515A1 Pyrimidine-5-carboxylic acid derivative |
| 04/27/2006 | WO2006043510A1 Ester derivative and pharmaceutical use thereof |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006042909A1 Nutrient supplement and use of the same |
| 04/27/2006 | WO2006042850A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 04/27/2006 | WO2006042733A2 Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/27/2006 | WO2006042732A1 Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mamal and compositions containing the same |
| 04/27/2006 | WO2006042666A1 R-(+)-α-LIPONIC ACID FOR THE PREVENTION OF DIABETES |
| 04/27/2006 | WO2006042408A1 Gh secretagogues and uses thereof |
| 04/27/2006 | WO2006042403A1 Process for producing natural immunobiotic extract and uses thereof |
| 04/27/2006 | WO2006017627A3 Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance |
| 04/27/2006 | WO2006008757A3 Stabilized pharmaceutical compositions of pravastatin |
| 04/27/2006 | WO2006002453A3 Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface |
| 04/27/2006 | WO2005123134A3 A controlled release delivery system for metformin |
| 04/27/2006 | US20060089404 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/27/2006 | US20060089394 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089349 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/27/2006 | US20060089347 Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | US20060089320 Modulation of type IIß phosphoinositide phosphate kinase |
| 04/27/2006 | US20060089312 Protease inhibitors |
| 04/27/2006 | US20060089311 Agonists and antagonists of ryzn for the treatment of metabolic disorders |
| 04/27/2006 | US20060088932 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
| 04/27/2006 | US20060088915 A G protein-coupled receptor protein for the treatment of digestive diseases |
| 04/27/2006 | US20060088913 Mutation associated with epilepsy |
| 04/27/2006 | US20060088573 Composition having action preventing or alleviating symtoms or diseases due to aging of blood vessels |
| 04/27/2006 | US20060088561 solidifying agent consists of long chain fatty alcohol; carrier is semi-solid at rest and liquefies upon application of shear forces |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088530 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes |
| 04/27/2006 | DE102004051014A1 Chemisch modifizierte Peptidanaloga Chemically modified peptide analogs |
| 04/27/2006 | CA2595212A1 Nutrient supplement and use of the same |
| 04/27/2006 | CA2584918A1 Cyanothiophenes, the production thereof and their use as medicaments |
| 04/27/2006 | CA2584398A1 Ester derivative and pharmaceutical use thereof |
| 04/27/2006 | CA2584383A1 Methods of using fatty-acid esters of estrogens and serotonin reuptake inhibiting compounds for reducing the body weight of a mammal and compositions containing the same |
| 04/27/2006 | CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 04/27/2006 | CA2584048A1 Multi-domain amphipathic helical peptides and methods of their use |
| 04/27/2006 | CA2583454A1 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | CA2583267A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | CA2583138A1 Process for producing natural immunobiotic extract and uses thereof |
| 04/27/2006 | CA2582464A1 Antisense modulation of ptp1b expression |
| 04/27/2006 | CA2581745A1 Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650210A1 Therapeutic agent for hyperpotassemia and bone disease |
| 04/26/2006 | EP1650205A1 Cyclohexanecarboxylic acid compound |
| 04/26/2006 | EP1650202A1 4,5-DIHYDRONAPHTHO [1,2-b] THIOPHENE DERIVATIVE |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1649854A1 Processed fat composition for preventing/ameliorating lifestyle-related diseases |
| 04/26/2006 | EP1648933A1 Long lasting insulin derivatives and methods thereof |
| 04/26/2006 | EP1648874A2 Piperazine derivatives and their use as therapeutic agents |
| 04/26/2006 | EP1648564A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors |
| 04/26/2006 | EP1648495A2 Compositions comprising gastrin compounds and their use in diabetes |
| 04/26/2006 | EP1648483A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/26/2006 | EP1648458A1 2-'4(phenylamino)-piperidin-1-yl]-n-phenyl-acetamine derivtives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 04/26/2006 | EP1648453A1 A synergistic pharmaceutical combination comprising cicletanine for the prevention or treatment of diabetes |
| 04/26/2006 | EP1648446A1 Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648445A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648444A1 Indol-7 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1648443A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 04/26/2006 | EP1648408A1 Azepine derivatives as pharmaceutical agents |
| 04/26/2006 | EP1534708B1 Purine derivatives and their use as antiproliferative agents |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1409485B1 Immunomodulating compounds |
| 04/26/2006 | EP1294240B1 Compositions and methods for body weight management |
| 04/26/2006 | EP1244454B1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/26/2006 | EP1155121B1 Compositions and methods for modulating serum cholesterol |
| 04/26/2006 | EP1009829B1 Adipocyte-specific protein homologs |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1764647A Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 04/26/2006 | CN1764466A Application of Cassia sophera L and its extractive in medicament for treating diabetes and improving the symptoms |
| 04/26/2006 | CN1764458A Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 04/26/2006 | CN1764390A Application of Cassia sophera L and its extractive in preparation of foodstuff for improving diabetes symptom |
| 04/26/2006 | CN1763030A Puerarin derivatives and their medical uses |
| 04/26/2006 | CN1762494A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 04/26/2006 | CN1762485A Aglycin group and its application in preparation of medicine or food for treating diabetes |
| 04/26/2006 | CN1762458A Hyperlipemia treating medicine and its preparation method |
| 04/26/2006 | CN1762442A Quick acting heart-benefiting hawthorn leaf ketone prepartion |
| 04/26/2006 | CN1762441A Chinese medicine composition for treating hyperlipemia and preparing method thereof |
| 04/26/2006 | CN1762440A Medicine for preventing and treating cardiovascular and cerebrovascular diseases |